Central Asian Research Index

Epidemiology&Health Data Insights, 2026, т. 2, № 5, с. ehdi051

Clinical Characteristics and Comorbidities of Pediatric Atopic Dermatitis in an Algerian Cohort: Relevance to Contemporary Therapeutic Management

Auda Ameur, Wiam Saadi, Charef Latroch, Ahlam Fatmi, Karim Bouziane Nedjadi, Véronique Desvignes

Pediatric Dermatologist, University of Oran 1, Oran, Algeria; Department of Pediatrics B, Amilcar Cabral, Oran University Hospital, Oran, Algeria
Department of Biology, Faculty of Nature, Life and Earth Sciences, University of Djillali Bounaama, Khemis Miliana, Algeria
Department of Pediatrics B, Amilcar Cabral, Oran University Hospital, Oran, Algeria
Department of Microbiology & Biochemistry, Faculty of Science, University of M’sila, M’sila, Algeria
Department of Pediatrics, Clermont-Ferrand University Hospital, Clermont-Ferrand, France; Scientific Committee, French Association of Ambulatory Pediatrics (AFPA), Saint-Géréon, France

Аннотация · Abstract

<b>Background:</b> Atopic dermatitis (AD) is a chronic relapsing inflammatory skin disease characterized by intense pruritus, xerosis, recurrent eczematous lesions, and impaired quality of life. Although AD is common in North Africa, data on its associated comorbidities in Algerian children remain scarce.<br /> <b>Objective:</b> To characterize the clinical profile and associated comorbidities of pediatric atopic dermatitis in an Algerian cohort and to review current therapeutic advances.<br /> <b>Methods:</b> We conducted a retrospective cross-sectional study including 53 children diagnosed with atopic dermatitis according to the Hanifin and Rajka criteria at the Pediatric Dermatology Unit of the University Hospital of Oran, Algeria, between January 2025 and January 2026. Demographic characteristics, clinical manifestations, allergic comorbidities, family history, and quality of life assessed using the Children's Dermatology Life Quality Index (CDLQI) were analyzed.<br /> <b>Results:</b> Atopic dermatitis represented <b>4.42%</b> of all dermatology consultations during the study period. The mean age was <b>6.7 years</b>, with a female predominance. Familial atopy was the most frequent comorbidity (<b>90.6%</b>), followed by familial asthma (<b>49.1%</b>) and familial eczema (<b>43.4%</b>). Among personal allergic comorbidities, asthma affected <b>26.4%</b>, allergic rhinitis <b>24.5%</b>, and allergic conjunctivitis <b>11.3%</b> of patients. Personal atopy was significantly associated with asthma (OR = <b>7.9</b>, 95% CI: <b>2.46–25.46</b>), food allergy (OR = <b>6.2</b>, 95% CI: <b>2.30–17.10</b>), allergic conjunctivitis (OR = <b>4.1</b>, 95% CI: <b>1.50–11.29</b>), and allergic rhinitis (OR = <b>3.5</b>, 95% CI: <b>1.38–9.22</b>). Quality of life was markedly affected, with sleep disturbances reported in <b>92.5%</b> of patients, stress and anxiety in <b>50.9%</b>, reduced daily activities in <b>34.0%</b>, and school absenteeism in <b>32.1%</b>.<br /> <b>Conclusion:</b> Pediatric atopic dermatitis in this Algerian cohort was characterized by a high burden of allergic comorbidities, a strong familial atopic background, and a substantial impact on quality of life. Early recognition of associated conditions and timely multidisciplinary management are essential to improve patient outcomes and may help reduce progression along the atopic march.

Сведения · Details